Eden Research Share Discussion Threads

[quazie12] 27/9/2021 14:59

NP how did you hear that SS had sold up ?

[neutralpov] 27/9/2021 11:50

@spadeychops

Shut up, fatso.

Your sort are the ones who will be screaming loudest for the blood of the BoD (post-torturing them) when the inevitable happens and the penny eventually drops for you.

It took me a lot less than five minutes to grasp what would take you five years or more (and it's still work-in-progress in what passes for your mind).

The question you should be asking is about whether or not the conduct of the principals and their accessories, nomad, PR liars etc has crossed the threshold where a COMPETENT REGULATOR (what we have is a CUCK) would be seeking prosecution.

But you are far too stoooooooooooooooooooooooooooooooooooooopid.

ROTFL ;D and popcorn-time, laughing at piggerant c*nts.


RENEWED TARGET PRICE: 0 pence.
ADVFN trolling again. Look at today's transactions before foolishly believing the real price went up, chuckle. It didn't. Google for EDEN RESEARCH PRICE

[pugugly] 26/9/2021 15:30

spadychops - Fair comment but "by their actions not words shall you know them" and erinvale1 makes some fair points - Management, as a result of the above statements not being fulfilled have shot themselves in both feet many times and have (imo) lost the confidence of many current investors and most potential new ones -

Would you buy supposedly fresh eggs from a farmer when many of those you had previously bought had turned out to be addled when you came to cook them?

[erinvale1] 26/9/2021 10:42

The Corteva deal may well deliver results in 3-5 years, as per RNS. Reviewing Eden's track record, the floor is littered with 'transformative' deals and promises which have failed to deliver. Some examples:

October 2004 Eden announced that heads of agreement have been agreed with Thallo Eco Products Corporation to distribute the nematode treatment product extensively in the US with minimum royalties of US$15m over 10 years. Outcome: No payments forthcoming.

Eden announced that significant sales would deliver in 2005/06. Outcome: Turnover 2005 zero; 2006 102,559! 

Jan 2006 Eden announced that the first product to be marketed under the Redestos agreement will be Eden’s encapsulated fungicidal product for treating botrytis, with anticipated revenues starting in 2007. Outcome: no marketing, Eden mired in EU approval process and regulation. 

May 2006: personal letter: 'obtaining approval for use of  3AEY in this major market (USA) within two years maximum". Outcome: 2021 - still no US approval. 

May 2006: (same letter): ' We do expect the product to soon be available in most major wine growing regions. Outcome: 2021 - sales minimal.

August 2007: 'concluded a major manufacturing and distribution agreement for Western Europe and the USA with Cheminova....this compliments the comapny's existing partnerships with Redestos SA in Greece and the Balkans, Zagro PTE in SE Asic and Xeda Intl in the post harvest sector. Cheminova is likely to start selling in Italy and Spain, then moving into France and Germany. Initial sales are likely to be small in 2008, with a full sales programme in 2009. Outome: non delivery. Sales still non-existent in 2012/2013 - £44k & £80k respectively.

[erinvale1] 25/9/2021 21:00

Yes indeed. the market’s reaction was a 15% fall in Eden’s share price It has remained on the floor thereafter.

[erinvale1] 25/9/2021 19:53

As someone commented on the demise of Eden’s sister company Environmental Recycling Technologies: ‘the only moral for investors is that a company needs more than a good product to succeed’. This was a reference to ERT’s arrogance. Unfortunately, Eden exhibits similar arrogance and seems to be going along the same destructive path.

[weyweyumfozo] 23/9/2021 13:44

I think you should go. You could take your tag team partner with you as one of his "care in the community" days out.

[ravenna23] 23/9/2021 12:12

GM tomorrow, no doubt none of the posters here will bother to attend, crooked accounts, hugely underpriced options and if you do bother to turn up the Chairman will shut down any difficult questions. A complete rort. Fools rush in.

[ravenna23] 23/9/2021 08:40

Well I guess if you bought these shares at 5p in order to avoid tax liabilities on gains and IHT there is a point to holding. However as the vast majority of AIM shares fail there is no logic to this. Holders are being plundered by the executive team, and if a less generous government is voted in the tax advantages could disappear. Extremely risky. Low daily volume also means that if you have a significant holding you will not be able to exit on bad news.

[weyweyumfozo] 22/9/2021 15:20

25 posts/week for six months regarding a stock he doesn't hold. If I remember correctly, before I put him on filter many months ago, he also said that he wasn't short on the stock.

Something problematic going on between his ears IMO.

[neutralpov] 22/9/2021 12:58

fatchops, you'se mentally ill (or a liar/fantasist who isn't holding this mangy dog's fleas). Seek help in either case. It's unlikely to be available on this DB.

[neutralpov] 22/9/2021 08:40

If EDEN could bio-engineer and patent and sell a cure for Stupid, then we enter into a paradigm:

(a) Because there would be no stupid people left, it would lose almost all its shareholders, but

(b) There being limitless demand for a cure for Stupid, it would make a vast amount of money! Which would attract any number of retail investors.

(c) O wait. It would all be bonused out, right?

Those with an IQ below 125, please excuse. The above isn't for you.